Day: April 19, 2023

Can B Corp. Reports Growth of 45% to Company All-Time High $6.7 Million Annual Revenue

Written by Customer Service on April 19, 2023. Posted in Earnings Releases And Operating Results.

Led by Significant Increase in Duramed Adjusted EBITDA Loss Decreased by 25% to $2.1 Million HICKSVILLE, NY, April 19, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Can B Corp. (OTCQB: CANB) (“Can B” or the “Company”), a health and wellness company specializing in developing, producing, and selling hemp-derived cannabinoid products, today announced the Company’s financial results for the twelve months ended December 31, 2022. Key Financial Highlights for 2022Revenue increased 45% to $6.7 million. Gross profit decreased 13% to $2.6 million. Gross margin decreased to 39.1%, due to a higher revenue percentage mix from Duramed. Adjusted EBITDA loss decreased by 25% to $2.1 million. Accounts receivable at $6.6 million. Inventory at $2.0 million. Total assets at $15.6 million. Total stockholders’ equity at $2.7 million....

Communities First Financial Corporation Earns Record $7.70 Million, or $2.43 per Diluted Share, for First quarter 2023

Written by Customer Service on April 19, 2023. Posted in Earnings Releases And Operating Results.

FRESNO, Calif., April 19, 2023 (GLOBE NEWSWIRE) — Communities First Financial Corporation (the “Company”) (OTCQX: CFST), the parent company of FFB Bank (the “Bank”), today reported net income increased 33% to $7.70 million, or $2.43 per diluted share, for the first quarter of 2023, compared to $5.79 million, or $1.84 per diluted share, for the first quarter of 2022, and increased 1% compared to $7.62 million, or $2.42 per diluted share, for the fourth quarter of 2022. First quarter 2023 results were highlighted by continued net interest margin expansion, which improved to 5.17% at March 31, 2023. All results are unaudited. First Quarter 2023 Highlights: As of, or for the quarter ended March 31, 2023, compared to the quarter ended March 31, 2022:Pre-tax, pre-provision income increased 36% to $10.77 million. Net income grew 33%...

UPDATE — Indaptus Therapeutics Presents Data Demonstrating Preclinical Efficacy of Decoy, its Bacteria-Based Immunotherapy Platform Technology, at the American Association for Cancer Research Conference 2023

Written by Customer Service on April 19, 2023. Posted in Public Companies.

Data presented were crucial to initiating its ongoing Phase 1 clinical trial with Decoy 20 in solid tumors NEW YORK, April 19, 2023 (GLOBE NEWSWIRE) — Indaptus Therapeutics, Inc. (Nasdaq: INDP, “Indaptus” or “the Company”), a biotechnology company focused on discovering and developing transformative therapeutics for patients, today announces data presented in a poster at the American Association for Cancer Research (AACR) annual scientific conference on the Company’s Decoy anti-tumor platform. The poster, titled, “A systemically administered killed bacteria-based multiple immune receptor agonist for pulsed anti-tumor immunotherapy,” authored by Michael J. Newman, Ph.D., the Company’s Founder and Chief Scientific Officer, was presented Tuesday, April 18, 2023. Highlights included:Decoy10 (a previous generation from the platform)...

dLocal to Host Investor Day on June 8, 2023 in New York

Written by Customer Service on April 19, 2023. Posted in Public Companies.

MONTEVIDEO, Uruguay, April 19, 2023 (GLOBE NEWSWIRE) — DLocal Limited (NASDAQ: DLO, “DLocal” or the “Company”), a technology-first payments platform enabling global enterprise merchants to connect with billions of consumers in emerging markets, today announced that it will host an Investor Day on Thursday, June 8, 2023, in New York City. This event is for equity analysts and institutional investors and will feature presentations by the dLocal management team. The event will begin at 8:30 am ET with breakfast, followed by presentations starting at 9:00 am. The Investor Day is open to the investment community and pre-registration is required by Thursday, June 1, 2023. To register, please email your name, title and company affiliation to info@nyinvestorday.com. Confirmation and additional event details will be provided to pre-registered...

Olyra Foods Secures Funding from Bimbo Ventures

Written by Customer Service on April 19, 2023. Posted in Public Companies.

Growing cookies and breakfast biscuits brand secures minority funding to drive future expansion NEW YORK, April 19, 2023 (GLOBE NEWSWIRE) — Olyra Foods, producer of organic and nutritional breakfast biscuits made with stone-milled ancient Greek grains today announces Bimbo Ventures, the venture capital arm of Grupo Bimbo, has made a minority investment in the company. Grupo Bimbo S.A.B de C.V., the world’s largest baking company with operations in 34 countries, is known for its category leading brands, innovative products, freshness and quality. The funding will help Olyra Foods further expand its presence in retail and on-line marketplaces. “Olyra, in a very authentic way, has tapped into a consumer need for more nutritious and delicious breakfast solutions,” said Constantino Matouk, VP of Bimbo Ventures. “We are excited...

Allarity Therapeutics, Inc. Announces Pricing of $7.5 Million Public Offering

Written by Customer Service on April 19, 2023. Posted in Public Companies.

Allarity Therapeutics, Inc. Announces Pricing of $7.5 Million Public Offering BOSTON, MA (April 19, 2023) — Allarity Therapeutics, Inc. (Nasdaq: ALLR) (“Allarity” or the “Company”), a clinical-stage pharmaceutical company developing novel oncology therapeutics together with drug-specific DRP® companion diagnostics for personalized cancer care, today announced the pricing of its “reasonable best efforts” public offering of 2,869,330 shares of common stock, 7,130,670 pre-funded warrants, and 10,000,000 common warrants to purchase 10,000,000 shares of common stock at an effective combined price of $0.75 per share and common warrant for aggregate gross proceeds of approximately $7.5 million, before deducting placement agent fees and other offering expenses. The warrants will have an exercise price of $0.85 per share, will be exercisable immediately...

Sunergy, a Provider of Residential Solar and Energy Efficiency Solutions, Signs Business Combination Agreement to Become a Public Company Through a Combination with ESGEN Acquisition Corp.

Written by Customer Service on April 19, 2023. Posted in Mergers And Acquisitions.

Sunergy Renewables, LLC (“Sunergy”) has entered into a definitive business combination agreement with ESGEN Acquisition Corp. (“ESGEN”). The combined company is expected to be listed on the Nasdaq Stock Exchange. Founded in 2005, Sunergy is a Florida-based leading provider of integrated rooftop solar, energy storage, and energy efficiency solutions to residential customers. Sunergy has a strong track record of financial performance and profitability, delivering approximately $123 million of revenue and approximately $11 million of EBITDA in 2022, underpinned by nearly 2,400 installations performed during the year. Sunergy is growing rapidly in the residential solar market with a differentiated sales approach, vertically integrated offerings, a geographic focus on high growth markets in Florida, Texas and Arkansas, and plans to expand...

PersonalRX Acquires New York-Based Pharmacy

Written by Customer Service on April 19, 2023. Posted in Mergers And Acquisitions.

Expands high-touch, one-on-one approach to all patients in New York including Medicaid EAST RUTHERFORD, N.J., April 19, 2023 (GLOBE NEWSWIRE) — PersonalRX, the home delivery pharmacy that places the patient at the center of care, today announced that it has acquired the MedMinder pharmacy in Brooklyn, NY. This marks PersonalRX’s growth into New York, and they will serve all New York-based patients – including those that are members of NY MRX, the Medicaid Pharmacy Program. PersonalRX, which is a Mail Service Pharmacy accredited by URAC, was created to support patients that take five or more medications. Designed with the patient in mind, PersonalRX provides patients with much needed personal attention. Medication is provided in dose packs, which are clearly labeled with the patient’s name, the drug and the date and time the medication...

Xalles Acquires Stake in Adaptive Analytics

Written by Customer Service on April 19, 2023. Posted in Mergers And Acquisitions.

Adaptive Provides Data Analytics and Artificial Intelligence Services to Multiple Industries Including the Financial Services Sector WASHINGTON, DC, April 19, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – Xalles Holdings Inc. (OTC: XALL), a fintech holding company providing technology and financial services solutions, today announced that it has executed a Share Exchange Agreement with Adaptive Analytics, Inc. (“Adaptive”) and completed the first closing event of the transaction for Xalles Technology Inc. to own 25% of Adaptive. An additional future closing event within a few months will complete the transaction for Adaptive to become a wholly owned subsidiary of Xalles Technology. Adaptive provides its clients with a cloud-based software platform that delivers an AI powered governance and control capability to enhance the data governance...

Qorvo® to Webcast Quarterly Earnings Conference Call on May 3, 2023

Written by Customer Service on April 19, 2023. Posted in Public Companies.

GREENSBORO, N.C., April 19, 2023 (GLOBE NEWSWIRE) — Qorvo® (Nasdaq: QRVO), a leading global provider of connectivity and power solutions, will host a conference call to review fiscal 2023 fourth quarter financial results on Wednesday, May 3, 2023, at 5:00 p.m. (ET). The conference call will be webcast live on the Company’s Investor Relations website at the following URL: https://ir.qorvo.com (under “Events & Presentations”). A telephone playback of the conference call will be available approximately two hours after the call’s completion and can be accessed by dialing 1-412-317-6671 and using the passcode 13737714. The playback will be available through the close of business on May 10, 2023. Qorvo will distribute fiscal 2023 fourth quarter financial results at approximately 4:00 p.m. (ET) on Wednesday, May 3, 2023. About...

Day: April 19, 2023

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice